Logo image
Vancomycin exposure and acute kidney injury outcome: A Snapshot From the CAMERA2 Study
Journal article   Open access   Peer reviewed

Vancomycin exposure and acute kidney injury outcome: A Snapshot From the CAMERA2 Study

J. Liu, S.Y.C. Tong, J.S. Davis, N.J. Rhodes, M.H. Scheetz, N. Anagostou, D. Andresen, S. Archuleta, N. Bak, A. Cass, …
Open Forum Infectious Diseases, Vol.7(12), Art. ofaa538
2020
pdf
Vancomycin Exposure.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

Among patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia from a prospective randomized clinical trial, acute kidney injury (AKI) rates increased with increasing vancomycin exposure, even within the therapeutic range. AKI was independently more common for the (flu)cloxacillin group. Day 2 vancomycin AUC ≥470 mg·h/L was significantly associated with AKI, independent of (flu)cloxacillin receipt.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

31 File views/ downloads
81 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.23 Antibiotics & Antimicrobials
1.23.173 MRSA and VRE
Web Of Science research areas
Immunology
Infectious Diseases
Microbiology
ESI research areas
Immunology
Logo image